9）Miyata M, Lee JY, Suzuki-Miyata S, Wang WY Xu H, Kai H, et al. Glucocorticoids suppress inflammation via the upregulation of negative regulator IRAK-M. Nat Commun 2015; 6: 6062.10）Schäcke H, Schottelius A, Döke WD, Strehlke P, Jaroch S, Schmees N, et al. Dissociation of transactivation from transrepression by a selective glucocorticoid receptor agonist leads to separation of therapeutic effects from side effects. Proc Natl Acad Sci U S A 2004; 101: 227-32.11）Lesovaya E, Yemelyanov A, Swart AC, Swart P, Haegeman G, Budunova I, et al. Discovery of Compound A−a selective activator of the glucocorticoid receptor with anti-inflammatory and anti-cancer activity. Oncotarget 2015; 6: 30730-44.12）Buttgereit F, Strand V, Lee EB, Simon-Campos A, Mccabe D, Genet A, et al. Fosdagrocorat（PF-04171327）versus prednisone or placebo in rheumatoid arthritis: a randomised, double-blind, multicentre, phaseⅡb study. RMD Open 2019; 5: e000889.13）Steer JH, Kroeger KM, Abraham LJ, Joyce DA. Glucocorticoids suppress tumor necrosis factor-alpha expression by human monocytic THP-1 cells by suppressing transactivation through adjacent NF-kappa B and c-Jun-activating transcription factor-2 binding sites in the promoter. J Biol Chem 2000; 275: 18432-40.14）Joosten LA, Helsen MM, van de Loo FA, van den Berg WB. Anticytokine treatment of established typeⅡcollagen-induced arthritis in DBA/1 mice: a comparative study using anti-TNFalpha, anti-IL-1alpha/beta and IL-1Ra. Arthritis Rheum 2008; 58: S110-22.221）Gilmore TD, Herscovitch M. Inhibitors of NF-kappaB signaling: 785 and counting. Oncogene 2006; 25: 6887-99.2）Greten FR, Arkan MC, Bollrath J, Hsu LC, Goode J, Miething C, et al. NF-kappaB is a negative regulator of IL-1beta secretion as revealed by genetic and pharmacological inhibition of IKKbeta. Cell 2007; 130: 918-31.3）Xavier AM, Anunciato AM, Rosenstock TR, Glezer I. Gene expression control by glucocorticoid receptors during innate immune responses. Front Endocrinol (Lausanne) 2016; 7: 31.4）Hosoya T, Shukla NM, Fujita Y, Yao S, Lao FS, Baba H, et al. Identification of compounds with glucocorticoid sparing effects on suppression of chemokine and cytokine production by rheumatoid arthritis fibroblast-like synoviocytes. Front Pharmacol 2020; 11: 607713.5）Chan M, Ahmadi A, Yao S, Sato-Kaneko F, Messer K, Pu M, et al. Identification of biologically active pyrimido[5,4-b]indoles that prolong NF-κb activation without intrinsic activity. ACS Comb Sci 2017; 19: 533-43.6）Hayer S, Vervoodeldonk MT, Denis MC, Armaka M, Hoffmann M, Bäcklund J, et al. 'SMASH' recommendations for standardised microscopic arthritis scoring of histological sections from inflammatory arthritis animal models. Ann Rheum Dis 2021; 80: 714-26.7）Xia X, Su C, Fu J, Zhang P, Jiang X, Xu D, et al. Role of α-lipoic acid in LPS/d-GalN induced fulminant hepatic failure in mice: studies on oxidative stress, inflammation and apoptosis. Int Immunopharmacol 2014; 22: 293-302.8）Asquith DL, Miller AM, McInnes IB, Liew FY. Animal models of rheumatoid arthritis. Eur J Immunol 2009; 39: 2040-4.文 献
元のページ ../index.html#36